Sherri L. Motzel
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Helicobacter pylori-related gastroenterology studies, Virus-based gene therapy research, Tuberculosis Research and Epidemiology, Bone health and treatments, Clostridium difficile and Clostridium perfringens research
Most-Cited Works
- → An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene(1998)369 cited
- → Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus(1995)321 cited
- → Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus Macaques(2004)283 cited
- → A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo(2000)157 cited
- Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I.(2002)
- → Isolation of Helicobacter cinaedi from the Colon, Liver, and Mesenteric Lymph Node of a Rhesus Monkey with Chronic Colitis and Hepatitis(2001)86 cited
- → PrimaTB STAT-PAK Assay, a Novel, Rapid Lateral-Flow Test for Tuberculosis in Nonhuman Primates(2007)64 cited
- → Novel Helicobacter species isolated from rhesus monkeys with chronic idiopathic colitis(2001)61 cited
- → N-Arylpiperazinone Inhibitors of Farnesyltransferase: Discovery and Biological Activity(1999)45 cited
- → Isolation and Characterization of a Novel Helicobacter Species, “ Helicobacter macacae ,” from Rhesus Monkeys with and without Chronic Idiopathic Colitis(2007)43 cited